Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells
Attiah, Bashnona, Alewine, Garrett, Easter, Mary-Kate, Coover, Robert A, Fahrenholtz, Cale D
Published in Pharmaceutics (01.03.2024)
Published in Pharmaceutics (01.03.2024)
Get full text
Journal Article
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner
Alewine, Garrett, Knight, Jerrica, Ghantae, Adithya, Mamrega, Christina, Attiah, Bashnona, Coover, Robert A., Fahrenholtz, Cale D.
Published in Journal of personalized medicine (30.06.2022)
Published in Journal of personalized medicine (30.06.2022)
Get full text
Journal Article
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-associated Malignant Peripheral Nerve Sheath Tumors
Attiah, Bashnona, Alewine, Garrett, Easter, Mary-Kate, Coover, Robert, Fahrenholtz, Cale
Published in American journal of pharmaceutical education (01.08.2023)
Published in American journal of pharmaceutical education (01.08.2023)
Get full text
Journal Article
Abstract 373: Silver nanoparticles are selectively cytotoxic to neurofibromin 1 deficient peripheral nerve sheath tumors
Alewine, Garrett, Ghantae, Adithya, Mamrega, Christina, Knight, Jerrica L., Attiah, Bashnona, Coover, Robert A., Fahrenholtz, Cale D.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article